Neoadjuvant atezolizumab in resectable NSCLC patients: Updated clinical and immunophenotyping results from a multicenter trial.
Year: 2019
Type: conference-abstract
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: Filiz Oezkan, Kai He, Dwight Hall Owen, Maciej Pietrzak, Valerie W. Rusch, Jamie E. Chaft, Rhonda Kitzler, Alan Nicholas, Katja Schulze, Ann Johnson, See Phan, Paul A. Bunn, Mark G. Kris, David J. Kwiatkowski, Bruce E. Johnson, Ignacio Ivan Wistuba, Jay M. Lee, Fred R. Hirsch, Gerard Lozanski, David Paul Carbone
Institutions: The Ohio State University, Sidney Kimmel Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Genentech, University of Colorado Denver, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, University of Colorado Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2958912176